Why BGPT?
logo

Author review tools

For authors: check each claim against the cited experiments and reported results before submission, with provenance and limits.Know what the science actually supports before you trust the answer.

Press Enter ↵ to check


     Quick Explanation



    Author snapshot — Yasushi Saeki

    Senior cell/ubiquitin biologist with many high-impact coauthored papers in Nature/Science-family journals (examples cited below) and strong citation influence across ubiquitin/proteasome research areas.

    • Key high-impact contributions: PINK1–Parkin ubiquitin phosphorylation (Nature 2014) and LUBAC/NEMO linear ubiquitin in NF-κB activation (Nature Cell Biol 2009) — highly cited foundational studies supporting Saeki’s role in ubiquitin pathway research



     Long Explanation



    Author Review — Yasushi Saeki

    Visual evidence: publication activity (counts by year)

    Visual evidence: top-cited papers (impact examples)

    Evidence-based synthesis (visual first, text second)

    1. High-impact collaborative contributor: Saeki is a coauthor on multiple influential ubiquitin/proteasome papers in high-impact journals (Nature, Nature Cell Biology, Nature Genetics, Molecular Cell). These works collectively have many hundreds to >1,000 citations each, indicating sustained influence in ubiquitin signaling and proteostasis pathways
    2. Focus areas & expertise: The topics repeatedly associated with Saeki’s work include ubiquitin, proteasome, NF-κB signalling, ribosome quality control, and branched ubiquitin chains — consistent across multiple high-quality experimental papers that use biochemical reconstitution, mass spectrometry, structural tools, and cellular genetics (examples: K48–K63 branched chains, ribosome-associated quality control)
    3. Productive collaborative network and consistent output: Multiple coauthorships with leaders in proteasome/ubiquitin research (e.g., Keiji Tanaka, Toshifumi Inada, Ken Ikeuchi) and frequent publications across 2000s–2020s indicate sustained active research presence. Open metrics (works_count ≈ 181; cited_by_count ≈ 11,430; h-index ≈ 54) are consistent with a senior, well-cited researcher (OpenAlex data summary provided separately by the user’s dataset).
    4. Methodological breadth and rigor: The representative papers use rigorous, complementary approaches (biochemistry, reconstitution, mass spectrometry, structural biology, cellular genetics, knockout/knockdown experiments) which strengthens causal inference and reproducibility across findings (examples cited above)
    5. Limitations & blind spots:
      • Many high-impact works are multi-author collaborations; Saeki is often a middle author — strong contribution likely, but attribution of leadership vs. contributor role should be assessed per-paper (first/last authorship used to infer leadership) (raw authorship lists available in each DOI-linked paper).
      • Open metrics provided (works_count, h-index, cited_by_count) are summaries but should be cross-validated with institutional pages, ORCID profile (ORCID: 0000-0002-9202-5453) and bibliographic databases for up-to-date provenance and to disambiguate name variants.
      • Field-level biases: ubiquitin/proteasome research is highly collaborative and generative of many follow-up papers; citation numbers alone do not guarantee sole intellectual primacy or conceptual novelty by a single coauthor.
    6. Overall scientific assessment (evidence-weighted):

      Based on multiple high-quality, highly-cited primary research articles in top-tier journals, strong methodological diversity (biochemistry, proteomics, structural modelling), and sustained publication activity, Yasushi Saeki shows the profile of a productive, technically rigorous researcher with recognized impact in ubiquitin and proteasome biology. However, leadership/influence on individual conceptual advances should be judged paper-by-paper (authorship position, contribution statements), and bibliometric summaries should be cross-checked for name disambiguation.

    Representative primary sources (examples used above)

    What would change this assessment?
    • If authorship contribution statements (or other provenance data) show consistent minor contributions rather than leading conceptual or experimental roles on the highly-cited papers, the perceived leadership role would be reduced.
    • Independent replication failures of key mechanistic claims in papers where Saeki is a primary contributor would lower confidence — but current highly cited literature has been built upon by many independent groups.
    • Updated bibliometric disambiguation that merges/splits publications for name variants could materially change aggregate metrics (works_count, h-index, total citations) and thus the quantitative portrait here.


    Feedback:   

    Updated: March 13, 2026

    BGPT Author Review



    Scientific Quality

    80%

    Substantial evidence of high scientific quality: many highly-cited, methodologically robust coauthored papers in top-tier journals across ubiquitin/proteasome biology; strengths include rigorous biochemical, proteomic, and cellular methods and sustained publication record; moderate caution because many key papers are multi-author and Saeki is often a middle author, so leadership on specific conceptual advances must be checked per-paper.



    Communication Quality

    80%

    Manifests clear experimental reporting and use of complementary methods across publications; papers published in high-quality journals with standard reporting suggest effective scientific communication; occasional highly technical language and collaborative multi-author formats can obscure individual contribution clarity.



    Author Novelty

    70%

    Work sits at the frontier of ubiquitin code/proteasome biology with several notable contributions to new mechanistic concepts (e.g., branched chains, ribosome ubiquitination), but novelty is often within collaborative large-team efforts rather than lone-author paradigm-shifting claims.



    Scientific Rigor

    80%

    Representative papers show rigorous controls, biochemical reconstitution, MS quantitation, and genetic perturbations; reproducibility indicators (high citation counts and follow-up work by others) are present, though per-paper inspection is required to evaluate sample sizes and statistical reporting in each study.

     Analysis Wizard



    Parsing OpenAlex/DOI lists and plotting per-paper citation trajectories to quantify influence over time using the provided top-works DOIs and counts_by_year data.



     Hypothesis Graveyard



    High citation counts imply sole conceptual leadership — false because citations often reflect team efforts and field relevance rather than single-author primacy.


    Bibliometric snapshots alone fully describe scientific quality — false because authorship contributions, reproducibility, and methodological novelty require paper-level scrutiny.

     Science Art


    Author Review: Yasushi Saeki Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT